alpha-aminopyridine has been researched along with amphetamine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatch, RC; Jernigan, AD | 1 |
| Achterrath-Tuckermann, U; Jakovlev, V; Stroman, F; Thiemer, K; von Schlichtegroll, A | 1 |
| Heron-Maxwell, CL; O'Neill, MF; Shaw, G | 1 |
| Harrison, AA; Liem, YT; Markou, A | 1 |
| Billinton, A; Duxon, MS; Quinn, LP; Stean, TO; Stratton, SC; Trail, B; Upton, N | 1 |
| Chevrette, J; Harrison, AA; Hoyer, D; Markou, A | 1 |
| Greenshaw, AJ; Hayes, DJ; Mosher, TM | 1 |
| Amantini, D; Antolini, M; Bifone, A; Cesari, N; Corsi, M; Gozzi, A; Martinelli, P; Massagrande, M; Montanari, D; Piccoli, L; Tessari, M; Turrini, G | 1 |
| Harland, AA; Maglathlin, R; McCorvy, JD; Nichols, DE | 1 |
| Fletcher, PJ; Higgins, GA; Soko, AD | 1 |
| Bagnol, D; Duranton, F; Faton, S; Lajoix, AD; Tassin, JP | 1 |
11 other study(ies) available for alpha-aminopyridine and amphetamine
| Article | Year |
|---|---|
Effect of intravenously-administered putative and potential antagonists of ethanol on sleep time in ethanol-narcotized mice.
Topics: 4-Aminopyridine; Alcoholic Intoxication; Aminophylline; Aminopyridines; Amphetamine; Animals; Azides; Benzodiazepines; Dextroamphetamine; Doxapram; Ethanol; Male; Mice; Naloxone; Physostigmine; Propranolol; Sleep; Thyrotropin-Releasing Hormone; Yohimbine | 1988 |
[General pharmacologic studies on the analgesic flupirtine].
Topics: Aminopyridines; Amphetamine; Analgesics; Animals; Anticonvulsants; Catalepsy; Central Nervous System; Diuresis; Dogs; Drug Interactions; Female; Hemodynamics; Hexobarbital; Humans; Hypnotics and Sedatives; In Vitro Techniques; Male; Mice; Morphine; Motor Activity; Muscle Tonus; Oxotremorine; Parasympatholytics; Rats; Respiration | 1985 |
5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB.
Topics: Aminopyridines; Amphetamine; Animals; Benzazepines; Cocaine; Dizocilpine Maleate; Dopamine Agonists; Drug Interactions; Female; Fluorobenzenes; Indoles; Mice; Motor Activity; Piperidines; Ritanserin; Serotonin Antagonists | 1999 |
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
Topics: Aminopyridines; Amphetamine; Amphetamine-Related Disorders; Animals; Body Weight; Brain; Depression; Disease Models, Animal; Drug Combinations; Electric Stimulation; Fluoxetine; Male; Mecamylamine; Neurons; Nicotine; Nicotinic Antagonists; Piperazines; Rats; Rats, Wistar; Reaction Time; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome; Synaptic Transmission; Tobacco Use Disorder | 2001 |
LABORAS: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminopyridines; Amphetamine; Angiotensin II; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Feeding Behavior; Haloperidol; Indoles; Injections, Intraventricular; Male; Motor Activity; Piperazines; Psychology, Experimental; Psychotropic Drugs; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats.
Topics: Affective Symptoms; Aminopyridines; Amphetamine; Animals; Brain; Drug Synergism; Hypothalamus, Posterior; Male; Motivation; Norepinephrine; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reward; Selective Serotonin Reuptake Inhibitors; Self Stimulation; Serotonin 5-HT1 Receptor Antagonists; Substance Withdrawal Syndrome | 2005 |
Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
Topics: Aminopyridines; Amphetamine; Animals; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nicotine; Nicotinic Agonists; Pyrazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2009 |
Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists.
Topics: Activity Cycles; Aminopyridines; Amphetamine; Animals; Behavior, Animal; Brain Mapping; Dioxanes; Magnetic Resonance Imaging; Motivation; Orexin Receptors; Phenylurea Compounds; Piperidines; Rats; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reward | 2011 |
A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference.
Topics: Aminopyridines; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Dose-Response Relationship, Drug; Indoles; Male; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2011 |
Impulsive action in the 5-choice serial reaction time test in 5-HT₂c receptor null mutant mice.
Topics: Aminopyridines; Amphetamine; Animals; Choice Behavior; Cocaine; Dose-Response Relationship, Drug; Ethylamines; Food Deprivation; Impulsive Behavior; Indoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Reaction Time; Receptor, Serotonin, 5-HT2C; Reinforcement Schedule; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2013 |
5-HT
Topics: Aminopyridines; Amphetamine; Animals; Arcuate Nucleus of Hypothalamus; Central Nervous System Stimulants; Eating; Feeding Behavior; Food Deprivation; Indoles; Male; Motivation; Motor Activity; Piperazines; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Reward; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Ventral Tegmental Area | 2018 |